Successful Management of Neonatal and Infantile Kaposiform Hemangioendothelioma with Low-Dose Sirolimus Therapy

Sirolimus is reportedly effective for kaposiform hemangioendothelioma. However, data on the efficacy of low-dose sirolimus therapy remain limited. This report presents two cases of neonatal and infantile kaposiform hemangioendothelioma associated with Kasabach-Merritt phenomenon successfully treated...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Yoshimasa Uematsu, MD, Ken-ichiro Konishi, MD, PhD, Kiyoshi Tanaka, MD, PhD, Hajime Takayasu, MD, PhD, Eiichiro Watanabe, MD, PhD, Takuji Tomari, MD, Hitoshi Isohata, MD, Hidehiko Nakanishi, MD. PhD, Daigo Ochiai, MD, PhD, Yusuke Kumamoto, MD, PhD
Format:	Artigo
Jezik:	Inglês
Izdano:	Elsevier 2025-09-01
Serija:	Journal of Pediatrics: Clinical Practice
Teme:	kaposiform hemangioendothelioma Kasabach-Merritt phenomenon neonatal serum level sirolimus
Online dostop:	http://www.sciencedirect.com/science/article/pii/S2950541025000237
Oznake:	Označite Brez oznak, prvi označite!